Koers Egyptian Int'l Pharmaceutical Industries Egyptian Exchange
Aandelen
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- EGP | - |
Omzet 2024 * | 7,1 mld. 148 mln. 138 mln. | Omzet 2025 * | 8,41 mld. 176 mln. 163 mln. | Marktkapitalisatie | 5,35 mld. 112 mln. 104 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 874 mln. 18,25 mln. 16,94 mln. | Nettowinst (verlies) 2025 * | 1,08 mld. 22,65 mln. 21,02 mln. | EV/omzet 2024 * | 1,67 x |
Nettoschuld 2024 * | 6,53 mld. 136 mln. 127 mln. | Nettoschuld 2025 * | 6,61 mld. 138 mln. 128 mln. | EV/omzet 2025 * | 1,42 x |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | - |
Dividendrendement 2024 * |
6,95% | Dividendrendement 2025 * |
8,34% | Vrij verhandelbaar | 45,72% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | - | |
Investor Relations Contact | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | - | |
Director/Board Member | - | - | |
Director/Board Member | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+19,98% | 43,48 mld. | |
+20,67% | 22,65 mld. | |
+14,56% | 14,73 mld. | |
+14,32% | 13,79 mld. | |
+44,72% | 12,04 mld. | |
-8,37% | 7,08 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+11,90% | 5,47 mld. |
- Beurs
- Aandelen
- Koers PHAR
- Koers